Contact Supplier

Shandong Boyuan Pharmaceutical Pemetrxed Dipotassium

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 2 USDMF, 2 Listed Suppliers

4 API Suppliers
2 USDMF
2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 2 FDA Orange Book, 2 Listed Dossiers

4 FDF Dossiers
2 FDA Orange Book
2 Listed Dossiers

Rochem Pemetrexed Dipotassium

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Z9slp4ow0y, 1438895-00-1, L-glutamic acid, n-(4-(2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-, potassium salt (1:2), Unii-z9slp4ow0y, Schembl15649196

Molecular Formula

C₂₀H₁₉K₂N₅O₆

Molecular Weight

503.6 g/mol

InChI Key

YQABXEMTTPRASZ-GXKRWWSZSA-L

FDA UNII

Z9SLP4OW0Y

1 2D Structure

Pemetrexed Dipotassium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

dipotassium;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate

2.1.2 InChI

InChI=1S/C20H21N5O6.2K/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27;;/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29);;/q;2*+1/p-2/t13-;;/m0../s1

2.1.3 InChI Key

YQABXEMTTPRASZ-GXKRWWSZSA-L

2.1.4 Canonical SMILES

C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[K+].[K+]

2.1.5 Isomeric SMILES

C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[K+].[K+]

2.2 Other Identifiers

2.2.1 UNII

Z9SLP4OW0Y

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Z9slp4ow0y

2. 1438895-00-1

3. L-glutamic Acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-, Potassium Salt (1:2)

4. Unii-z9slp4ow0y

5. Schembl15649196

2.4 Create Date

2019-01-23

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₁₉K₂N₅O₆
Molecular Weight	503.6 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	7
Exact Mass	503.0609463 g/mol
Monoisotopic Mass	503.0609463 g/mol
Topological Polar Surface Area	193 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	737
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3